Giampaolo Bianchini, MD, IRCCS San Raffaele Hospital, Milan, Italy, provides an Italian perspective on the impact of the COVID-19 pandemic on breast cancer treatment and management, and outlines the personalized risk-benefit ratio adaption of breast cancer care implemented as a result of the pandemic. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
